Epileptogenic ion channel mutations: from bedside to bench and, hopefully, back again.
Mutations of genes coding for ion channels cause several genetically determined human epileptic syndromes. The identification of a gene variant linked to a particular disease gives important information, but it is usually necessary to perform functional studies in order to completely disclose the pathogenic mechanisms. The functional consequences of epileptogenic mutations have been studied both in vitro and in vivo with several experimental systems, studies that have provided significant knowledge on the pathogenic mechanisms that leads to inherited human epilepsies, and possibly also on the pathogenic mechanisms of non-genetic human epilepsies due to "acquired channelopathies". However, several open issues remain and difficulties in the interpretation of the experimental data have arisen that limit translational applications. We will highlight the value and the limits of different approaches to the study of epileptogenic channelopathies, focussing on the importance of the experimental systems in the assessment of the functional effects of the mutations and on the possible applications of the obtained results to the clinical practice.
Mantegazza
Massimo
M
Institut de Pharmacologie Moléculaire et Cellulaire, CNRS UMR6097 and University of Nice-Sophia Antipolis, 660 route des Lucioles, 06560 Valbonne, France. mantegazza@ipmc.cnrs.fr
Rusconi
Raffaella
R
Scalmani
Paolo
P
Avanzini
Giuliano
G
Franceschetti
Silvana
S
D000818:Animals; D053447:Channelopathies / Q000150:complications / Q000235:genetics*; D004195:Disease Models, Animal; D004827:Epilepsy / Q000209:etiology / Q000235:genetics / Q000473:pathology; D006801:Humans; D007473:Ion Channels / Q000235:genetics*; D009154:Mutation / Q000235:genetics*
D007473:Ion Channels